Catalyst Wire Dossier Catalyst Wire Dossier

SYN008

· CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYN008, covering 2021-06-29 to 2021-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous Urticaria [Phase 3]

See pricing